期刊文献+

Nonlinearity of optoacoustic signals and a new contrast mechanism for imaging

原文传递
导出
摘要 Optoacoustic signals behave nonlinearly at light fluences above a few mJ/cm^(2),which may affect the interpretation and quantification of measurements.It has been proposed that optoacoustic nonlinearity arises from the heat-induced formation of nanobubbles or changes in local thermo-physical parameters.However,such explanations are only valid at much higher fluences than typically used in biomedical optoacoustic imaging(>20 mJ/cm^(2))or in the presence of materials with high absorption coefficients such as gold nanoparticles.We propose herein that electromagnetic permittivity changes in response to photon absorption are major source of optoacoustic signal nonlinearity at low fluences.We provide theoretical and experimental evidence that supports this postulation and show that optoacoustic pressure responses due to permittivity changes,which are function of thermally excited third-order nonlinear susceptibility,can explain the nonlinear behavior of the optoacoustic signal.Since different materials exhibit different thermally excited third-order nonlinear susceptibility,this property could function as a new contrast mechanism that can identify the sensitivity of a substance’s dielectric constant to photon-induced temperature changes.Consequently,we propose an imaging method based on nonlinear optoacoustic signals that exploits this newly identified contrast mechanism.These findings may have far-reaching implications for improving the accuracy of optoacoustics and utilizing the proposed new contrast mechanism would advance our understanding of cellular and tissue functionality.
出处 《Light: Science & Applications》 2025年第5期1420-1432,共13页 光(科学与应用)(英文版)
基金 funded by the European Union under the 7th Framework Program grant agreement no 605162(BERTI) the European Union’s Horizon 2020 research and innovation programme under grant agreement no.687866(INNODERM)and no.862811(RSENSE) the Deutsche Forschungsgemeinschaft(DFG)as part of the CRC 1123(Z1) funding from the European Commission grant agreement No 801347(SENSITIVE) Spanish Ministry of Economy and Competitiveness(MINECO)Grant FIS2016-77892-R the Alexander von Humboldt Postdoctoral Fellowship program.
  • 相关文献

参考文献1

二级参考文献28

  • 1[1]Landis SH,Murray T,Bolden S,Wingo PA.Cancer statistics,1999.CA Cancer J Clin 1999; 49:8-31,1
  • 2[2]Visser O,Siesling S,Dijck JAAM.Incidence of Cancer in the Netherlands 1999/2000.11th ed,Utrecht:Association of Comprehensive Cancer Centres,2003:22-23
  • 3[3]Ferlay J,Bray F,Pisani P,Parkin DM.GLOBOCAN 2000; cancer incidence,mortality and prevalence worldwide.Version 1.0.IARC CancerBase No.5.Lyon; IARC Press,2001
  • 4[4]Sagar PM,Pemberton JH.Surgical management of locally recurrent rectal cancer.Br J Surg 1996; 83:293-304
  • 5[5]Frykholm GJ,Pahiman L,Glimelius B.Treatment of local recurrences of rectal carcinoma.Radiother Oncol 1995; 34:185-194
  • 6[6]van den Brink M,Stiggelbout AM,van den Hout WB,Kievit J,Klein Kranenbarg E,Marijnen CA,Nagtegaal ID,Rutten HJ,Wiggers T,van de Velde CJ.Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy.J Clin Oncol 2004; 22:3958-3964
  • 7[7]Camilleri-Brennan J,Steele RJ.The impact of recurrent rectal cancer on quality of life.Eur J Surg Oncol 2001; 27:349-353
  • 8[8]Heald RJ,Ryall RD.Recurrence and survival after total mesorectal excision for rectal cancer.Lancet 1986; 1:1479-1482
  • 9[9]MacFarlane JK,Ryall RD,Heald RJ.Mesorectal excision for rectal cancer.Lancet 1993; 341:457-460
  • 10[10]Kapiteijn E,Marijnen CA,Nagtegaal ID,Putter H,Steup WH,Wiggers T,Rutten HJ,Pahlman L,Glimelius B,van Krieken JH,Leer JW,van de Velde CJ.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.N Engl J Med 2001; 345:638-646

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部